De novo malignancy following liver transplantation: a single-center study.
Levy
M
M
Baylor University Medical Center, Dallas, Texas.
Backman
L
L
Husberg
B
B
Goldstein
R
R
McMillan
R
R
Gibbs
J
J
Gonwa
T A
TA
Holman
M
M
Klintmalm
G
G
D000328:Adult; D005260:Female; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D015994:Incidence; D016031:Liver Transplantation / Q000009:adverse effects* / Q000276:immunology; D008223:Lymphoma / Q000453:epidemiology / Q000209:etiology*; D008297:Male; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000627:therapeutic use; D009369:Neoplasms / Q000453:epidemiology / Q000209:etiology*; D012189:Retrospective Studies; D012878:Skin Neoplasms / Q000453:epidemiology / Q000209:etiology
D016853:Muromonab-CD3